Pregled po CROSBI profilu: Pero Draganić (CROSBI Profil: 12753, MBZ: 145152)
Pronađeno 97 radova
-
1.Betica Radić, Ljiljana; Džono Boban, Ankica; Draganić, PeroUtjecaj COVID-19 pandemije na izvanbolničku potrošnju antibiotika u Republici Hrvatskoj // Knjiga sažetaka: 13. hrvatski kongres kliničke mikrobiologije i 10. hrvatski kongres o infektivnim bolestima s međunarodnim sudjelovanjem
Šibenik, 2022. PO-29, 1 (poster, domaća recenzija, sažetak, znanstveni) -
2.Draganić, PeroSpecifics and Tendencies of Drug Consumption in Croatia in the Last Five Years // Pharmaca 2022, 52:4
Opatija, Hrvatska, 2022. str. 61-61 (pozvano predavanje, domaća recenzija, sažetak, znanstveni) -
3.Draganić, PeroAvailability of oncological drugs in Croatia and consumption in the last decade // Farmaca 2022, 52:3
Pula, Hrvatska, 2022. str. 57-57 (pozvano predavanje, domaća recenzija, sažetak, znanstveni) -
4.Draganić, Pero; Oštarčević, SuzanaPotrošnja lijekova u Hrvatskoj od 2016. do 2020. godine, 2021. (domaća recenzija, ostalo).
-
5.Tomasović, Sanja; Košćak Lukač, Jelena; Sremec, Josip; Klepac, Nataša; Draganić, Pero; Bielen, IvanEpidemiology of Pharmacological Treatment of Multiple Sclerosis in Croatia // Psychiatria Danubina, 33 (2021), 13; 204-208 (međunarodna recenzija, članak, znanstveni)
-
6.Draganić, Pero; Oštarčević, SuzanaPotrošnja lijekova u Hrvatskoj od 2015. do 2019. godine, 2020. (domaća recenzija, ostalo).
-
7.Draganić, Pero"Virtual ISPOR 2020", Research Abstract Review Committee Member – reviewer; 18-20 May, 2020, 2020. (međunarodna recenzija, ostalo).
-
8.Draganić, Pero"Virtual ISPOR Europe 2020", Research Abstract Review Committee Member – reviewer; November 16- 19, 2020, 2020. (međunarodna recenzija, ostalo).
-
9.Malinowski, Krzysztof Piotr 1*; Kawalec, Paweł 1; Trabka, Wojciech 2; Sowada, Christoph 1; Petrova, Guenka 3; Manova, Manoela 3, 4; Savova, Alexandra 3, 4; Draganić, Pero 5, 6; Slaby, Juraj 7; Männik, Agnes 8 et al.Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe // Orphanet journal of rare diseases, 15 (2020), 1; 10.1186, 13 doi:.org/10.1186/s13023-020-01556-9 (međunarodna recenzija, članak, znanstveni)
-
10.Draganić, Pero; Škribulja, Marija; Oštarčević, SuzanaPotrošnja lijekova u Hrvatskoj od 2014. do 2018. godine, 2019. (domaća recenzija, ostalo).
-
11.Draganić, Pero"ISPOR Europe 2019", Research Abstract Review Committee Member – reviewer; 2-6 November, 2019, Copenhagen, Denmark, 2019. (međunarodna recenzija, ostalo).
-
12.Draganić, Pero"ISPOR Latin America 2019" - Research Abstract Review Committee Member – reviewer; ISPOR Latin America 2019, 12-14 September 2019, Bogota, Colombia, 2019. (međunarodna recenzija, ostalo).
-
13.Draganić, Pero"ISPOR 2019”, Research Abstract Review Committee Member – reviewer; "ISPOR 2019”, May 18-22, 2019, New Orleans, LA, USA, 2019. (međunarodna recenzija, ostalo).
-
14.Malinowski, Krzysztof Piotr; Kawalec, Pawel; Trąbka, Wojciech; Czech, Marcin; Petrova, Guenka; Manova, Manoela; Savova, Alexandra; Draganić, Pero; Vostalová, Lenka; Slabý, Juraj et al.Reimbursement Legislations and Decision Making for Orphan Drugs in Central and Eastern European Countries // Frontiers in Pharmacology, 10 (2019), 487; 101371, 16 doi:10.3389/fphar.2019.00487. eCollection 2019. (međunarodna recenzija, članak, znanstveni)
-
15.Draganić, Pero; Škribulja, Marija; Oštarčević, SuzanaPotrošnja lijekova u Hrvatskoj 2013.-2017., 2018. (domaća recenzija, ostalo).
-
16.Draganić, Pero; Škribulja, Marija; Oštarčević, SuzanaPotrošnja lijekova u Hrvatskoj od 2012. do 2016. godine, 2018. (domaća recenzija, ostalo).
-
17.Draganić, Pero"ISPOR Europe 2018", Research Abstract Review Committee Member – reviewer; November 10-14, 2018, Barcelona, Spain, 2018. (međunarodna recenzija, ostalo).
-
18.Draganić, Pero“ISPOR 2018“, Research Abstract Review Committee Member – reviewer; ISPOR 23rd Annual International Meeting, May 19-23, 2018, Baltimore, MD, USA, 2018. (međunarodna recenzija, ostalo).
-
19.Kamusheva, Maria; Manova, Manoela; Savova, T. Alexandra; Petrova, I. Guenka; Mitov, Konstantin; Harsányi, Andras; Kaló, Zoltan; Márky, Kristof; Kawalec, Pawel; Angelovska, Bistra et al.Comparative Analysis of Legislative Requirements about Patients' Access to Biotechnological Drugs for Rare Diseases in Central and Eastern European Countries // Frontiers in Pharmacology, 9 (2018), 795; 103389, 15 doi:10.3389/fphar.2018.00795 (međunarodna recenzija, članak, znanstveni)
-
20.Draganić, Pero; Žeželić, Saša; Oštarčević, SuzanaPotrošnja lijekova u Hrvatskoj od 2011. do 2015. godine, 2017. (domaća recenzija, ostalo).
-
21.Draganić, Pero"ISPOR Europe 2017", Research Abstract Review Committee Member – reviewer; November 4-8, 2017, Glasgov, Scotland, UK, 2017. (međunarodna recenzija, ostalo).
-
22.Draganić, Pero"ISPOR 6th Latin America Conference 2017" - Research Abstract Review Committee Member – reviewer; September 15-17, 2017, Sao Paulo, Brazil, 2017. (međunarodna recenzija, ostalo).
-
23.Draganić, Pero“ISPOR 22nd Annual International Meeting 2017”, Research Abstract Review Committee Member – reviewer; May 20-24, 2017, Boston, MA, USA, 2017. (međunarodna recenzija, ostalo).
-
24.Kawalec, Pawel; Tesar, Tomas; Vostalova, Lenka; Draganic, Pero; Manova, Manoela; Savova, Alexandra; Petrova, Guenka; Rugaja, Zinta; Männik, Agnes; Sowada, Christoph et al.Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review // Frontiers in Pharmacology, 8 (2017), 892; 10.3389, 16 doi:10.3389/fphar.2017.00892 (međunarodna recenzija, članak, znanstveni)
-
25.Kawalec, Pawel; Stawowczyk, Ewa; Tesar, Tomas; Skoupa, Jana; Turcu-Stiolica, Adina; Dimitrova, Maria; Petrova, Guenka I.; Rugaja, Zinta; Männik, Agnes; Harsanyi, Andras; Draganic, PeroPricing and Reimbursement of Biosimilars in Central and Eastern European Countries // Frontiers in Pharmacology, 8 (2017), 288; 288, 14 doi:10.3389/fphar.2017.00288 (međunarodna recenzija, članak, znanstveni)
